Novogene Co., Ltd. (688315.SH) recorded a net profit of 194 million yuan for the fiscal year 2024, representing a year-on-year growth of 9.20%.

Novogene Co., Ltd. (688315.SH) released its performance report for the year 2024, showing that during the reporting period, the company achieved a total operating income of 2.11 billion yuan, a year-on-year increase of 5.45%; the net profit attributable to the owner of the parent company was 1.94 billion yuan, a year-on-year increase of 9.20%. During the reporting period, against the backdrop of changes in the macroeconomic environment and increasing industry competition, the company actively responded to market demand, adhered to a strategy of leading in total costs, extended product services, deepened global customer operations, accelerated overseas market layout, and continued to expand overseas business revenue. At the same time, the company increased investment in new product and technology research and development, enhanced innovation capabilities, reduced costs internally, promoted digital upgrades and process optimization reforms, comprehensively improved management efficiency, and achieved steady revenue growth, with profitability indicators such as gross profit margin and profit margin continuously rising.